BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 28, 2020
View Archived Issues
AD and HHV: Still a mystery
Read More
Glial cells contribute to brain control of aging
Read More
New phase III trial evaluates MK-6482 in advanced renal cell carcinoma
Read More
Genetic removal of mast cell Tph1 protects mice from developing obesity and insulin resistance
Read More
FDA approves Dificid for C. difficile infection in children age 6 months and older
Read More
FDA clears NeoImmuneTech's IND to study NT-I7 plus pembrolizumab in advanced solid tumors
Read More
Otsuka reports promising topline data from Japanese trials of fremanezumab in migraine
Read More
LNA-anti-miR-150 ameliorates FSGS in vivo
Read More
Targeting SK1 overcomes resistance to immune checkpoint inhibitors in melanoma
Read More
Retinoic X receptor as therapeutic target for poststroke recovery
Read More
Vallon Pharmaceuitcals presents results on manipulated dextroamphetamine sulfate
Read More
New hydroxyacid oxidase 1 inhibitors discovered at Orfan Biotech
Read More
Gilead describes new IDO-1 inhibitors
Read More
Novartis Inflammasome Research describes new NLRP3 inflammasome inhibitors
Read More
New CRLF2 ligands identified at Korea University Research and Business Foundation
Read More
GeoVax and BravoVax sign letter of intent to codevelop 2019-nCoV coronavirus vaccine
Read More
FDA approves Trijardy XR for type 2 diabetes
Read More
miR-3064-5p found to have prognostic value in HCC
Read More
PULSAR trial of sotatercept in pulmonary arterial hypertension meets primary endpoint
Read More
Sichuan Kelun-Biotech Biopharmaceutical discloses RORC agonists
Read More
FDA clears INDs for Surface Oncology's antibody candidates SRF-617 and SRF-388
Read More
Study suggests direct amino acid toxicity could account for caloric restriction benefits
Read More